Use of surgical procedures is one of the most important methods for the treatment of orthopedic patients \[[@B1]\]. Local soft tissue injury, internal fixation, surgical bleeding, long operation duration, and other factors lead to increased risk of incision infection \[[@B2]\]. Incision infection is still the most common early complication after operations. It directly increases the medical expenses of patients, prolongs hospitalization, delays fracture healing, necessitates reoperation or multiple operations, and makes patients lose the trust of surgeons \[[@B3]\]. If infection is difficult to control, amputation may be indicated, which can even be life-threatening \[[@B3]\].

The basic idea of bone infection control is to eliminate bacteria that cannot be killed by antibiotic agents, improve body immunity, create an environment conducive to enhance body immunity and function of antibiotic agents, and kill planktonic bacteria through antibiotic agents. Thus, in the management of post-operative infection, besides effective debridement and drainage, it is particularly important to analyze the epidemiologic status and drug resistance of pathogens.

Mixed infection refers to infection caused by two or more pathogens at the same time (e.g., a patient experiencing nasal gangrene and epidemic lymphangitis because of bovine tuberculosis and brucellosis). *Staphylococcus aureus* and *Pseudomonas aeruginosa* are often found in the wounds of patients with extensive burns and whose condition is complex and difficult. Such patients often need large doses of antibiotic agents, which may not always control the infection effectively. In addition, synergistic effects among various pathogenic micro-organisms in mixed infections, such as synergistic gangrene caused by hemolytic *S. aureus* and *Streptococcus microaerogenes*, promote the reproduction of anaerobic bacteria because of the consumption of oxygen by aerobic bacteria.

Initially, the wound appears as local cellulitis, with red periphery and purple center, then progresses to gangrene and ulcer, and gradually expands. The ulcer edge is purple-black and accompanied by severe pain. Therefore, one of the intractable aspects of surgical site mixed infection is the increase in the number of pathogenic bacteria, and adjustment of antibiotic doses is still not effective in controlling infection.

Many studies have investigated the interaction of pathogenic bacteria at the molecular level, but few studies have focused at the human ecologic environment level to determine whether epidemiologic and drug resistance of pathogenic bacteria varied because of the interaction between multiple pathogens on mixed infection. Infection and mixed infection are not uncommon in an orthopedic surgical incision because of its proximity to the body surface, long operation duration, excessive bleeding during operation, and the need for internal implants. Thus, to improve the control and management of mixed infection in orthopedic incisions, this study aimed to observe and understand the characteristics of pathogenic bacteria and drug resistance of mixed infection after orthopedic surgical procedures.

Methods {#s001}
=======

General information and patients {#s002}
--------------------------------

This study retrospectively analyzed 86 patients with mixed infection of a surgical incision among 533 patients with nosocomial infection after orthopedic operation in the First Affiliated Hospital of Nanchang University from March 2012 to July 2017. The inclusion criteria were as follows: (1) Complete clinical data; (2) sterile surgical treatment; (3) **diagnosis of surgical site infection** according to the criteria developed by the Joint International Commission Health Organization (2002) (i.e., a large amount of purulent material was drained from the wound; the wound split spontaneously with purulent drainage; wound drainage culture results were positive, or Gram stain results were positive; the surgeon noticed swelling or drainage from the incision, identified an infection, and opened the incision); (4) diagnosed as nosocomial infection according to the diagnostic criteria for nosocomial infection \[[@B4]\]; (5) positive bacterial culture in secretion or incision drainage fluid; and (6) more than one strain in a single culture.

The exclusion criteria were (1) repeated isolation of strains from the same surgical site in the same patient; (2) contaminated bacteria; (3) infectious diseases; (4) complicated with autoimmune diseases; (5) complicated with infectious diseases; (6) complicated with severe diseases; and (7) impaired organ function.

Examination method {#s003}
------------------

The isolation media for the drug susceptibility tests were 90-mm Chinese blue agar medium (Shanghai Kemajia Biotechnology Co., Ltd.) and Colombian blood agar medium (Shanghai Kemajia Biotechnology Co., Ltd.). Pathogen identification and the drug susceptibility test were performed using the VITEK-2 Compact automatic bacterial tester (bioMerieux, Hazelwood, MO). Drug sensitivity was evaluated according to the 2017 Clinical and Laboratory Standards Institute standards.

The study was approved by the Ethics Committee of The First Affiliated Hospital of Nanchang University (approval \#20170720), and all participants provided written informed consent.

Statistical methods {#s004}
-------------------

SPSS 19.0 Statistical Software was used to establish a database and perform statistical analyses. The data normality test was performed using a normal curve histogram, Q-Q graph, P-P graph K-S, and Shapiro-Wilk tests. These data were not normally distributed; therefore, non-parametric tests, such as Mann-Whitney and Wilcoxon non-rank sum tests, were used in comparing differences, which were deemed statistically significant if p \< 0.05.

Results {#s005}
=======

Bacterial distribution {#s006}
----------------------

A total of 218 bacterial strains from 86 patients were included in this study. There were 152 gram-negative bacteria (69.72%), 65 gram-positive bacteria (29.82%), and one fungus (0.46%). *Enterobacter cloacae* (12.3%), *S. aureus* (9.6%), *P. aeruginosa* (7.7%), *Escherichia coli* (7.5%), and *Baumann/Acinetobacter haemolyticus* (6.8%) were the most common ([Table 1](#tb1){ref-type="table"}). The foot (32.56%), leg (23.74%), forearm (16.96%), and knee (15.81%) were the most common sites of infection ([Fig. 1](#f1){ref-type="fig"}).

![Surgical site distribution of mixed infection.](sur.2019.276_figure1){#f1}

###### 

Distribution of Bacterial Species

  Culture                        Number of bacteria   Constituent ratio (%)
  ------------------------------ -------------------- -----------------------
  *Enterobacter cloacae*         27                   12.3
  *Staphylococcus aureus*        21                   9.6
  *Pseudomonas aeruginosa*       17                   7.7
  *Escherichia coli*             16                   7.5
  *Acinetobacter haemolyticus*   15                   6.8
  *Aeromonas hydrophila*         13                   5.9
  *Staphylococcus epidermidis*   10                   4.5
  *Klebsiella pneumoniae*        9                    4.1
  *Enterobacter aerogenes*       8                    3.6
  *Xanthomonas maltophilia*      7                    3.2
  *Enterococcus faecalis*        6                    2.7
  *Morganella morii*             4                    1.6
  Other                          65                   29.8
  Total                          218                  100

There were 2-7 kinds of bacterial infections in each wound, of which two kinds of bacteria caused the most infections, accounting for 65.1% of the analyzed cases. With the increase in the number of strains, the number of infections decreased. There were four combinations of pathogenic bacteria: all gram-negative bacteria (55.81%), mixed gram-negative bacteria and gram-positive bacteria (30.23%), positive gram-positive bacteria (12.79%), and mixed gram-positive bacteria and fungi (1.16%). There are only two combinations of positive bacteria in the combinations of all gram-positive bacteria, but not in the combinations of all gram-positive bacteria. Mixed infections caused by more than two gram-positive bacteria were found ([Table 2](#tb2){ref-type="table"}).

###### 

Combination Mode of Bacterial Species

  Combinations   All G+   All G---   G+、G---mixing   G+、fungi mixing   Total
  -------------- -------- ---------- ---------------- ------------------ -------
  2              28       11         17               1                  56
  3              10       0          5                0                  15
  4              8        0          4                0                  12
  5              1        0          0                0                  1
  6              1        0          0                0                  1
  Total          48       11         26               1                  86

Numb = number of strains, G+ = gram-positive bacteria; G--- = gram-negative bacteria.

Drug resistance of pathogenic bacteria {#s007}
--------------------------------------

Gram-negative bacteria showed good susceptibility to cefoperazone/sulbactam sodium (11.1%) and meropenem (13.3%) and drug resistance to ampicillin (82%), aztreonam (70%), and amoxicillin/clavulanate potassium (75%) ([Table 3](#tb3){ref-type="table"}). Gram-positive bacteria were highly susceptible to linezolid (0%). Furantoin (resistance rate 0%) showed good sensitivity, and ampicillin (resistance rate 100%) and amoxicillin/clavulanate potassium (75%) had high drug resistance ([Table 4](#tb4){ref-type="table"}). This is consistent with the bacterial resistance of 447 cases of single bacterial surgical site infections during the same period ([Table 5](#tb5){ref-type="table"}). Patients with mixed incision infection were defined as patients with simple postoperative infection. The 95% confidence interval for extended hospital stay was (9.8-20.6) days.

###### 

Resistance of Gram-Negative Bacteria to Antibiotic Agents

  Antibacterials                    Aerobacter cloacae   E. coli   Pseudomonas aeruginosa   Acinetobacter haemolyticus   Aeromonas hydrophila   Amount                           
  --------------------------------- -------------------- --------- ------------------------ ---------------------------- ---------------------- -------- ---- ------ ---- ------ ------
  Ampicillin                        26                   100       15                       53.3                         1                      100      1    100    6    66.7   82
  piperacillin                      27                   40.7      15                       53.3                         13                     7.7      13   61.5   0    0      41
  Amoxicillin / clavulanic acid     24                   83.3      15                       33.3                         9                      100      9    88.9   12   83.3   75
  Ampicillin / sulbactam            8                    50        8                        50                           5                      60       8    100    5    60     65
  Cefoperazone / sulbactam sodium   9                    11.1      4                        0                            3                      33.3     5    20     3    0      12.5
  Cefoperazone                      11                   45.5      8                        37.5                         9                      33.3     7    71.4   6    16.7   41
  Ceftazidime                       27                   22.2      16                       37.5                         13                     30.8     13   69.2   13   30.8   35
  Ceftriaxone                       16                   50        10                       60                           11                     27.3     12   58.3   10   30     46
  Cefotaxime                        19                   31.6      11                       54.5                         11                     36.4     13   69.2   11   45.5   46
  Cefepime                          18                   27.8      11                       54.5                         9                      44.4     12   66.7   6    0      39
  Cefoxitin                         26                   69.2      15                       13.3                         10                     30       7    100    13   38.5   49
  Aztreonam                         20                   80        11                       81.8                         3                      33.3     1    100    11   45.5   70
  Imipenem                          27                   63        15                       46.7                         11                     81.8     7    100    8    62.5   66
  Meropenem                         15                   13.3      7                        28.6                         3                      33.3     5    80     7    28.6   30

###### 

Resistance of Gram-Positive Bacteria to Antibiotic Agents

  Antibacterials                       Staphylococcus aureus   Staphylococcus epidermidis   Enterococcus faecalis   Overall (%)                
  ------------------------------------ ----------------------- ---------------------------- ----------------------- ------------- ----- ------ ------
  Penicillin                           3                       66.7                         ---                     ---           2     50     60
  Ampicillin                           9                       100                          5                       100           3     0      100
  Oxacillin                            19                      15.8                         10                      70            1     100    36.7
  Gentamicin                           20                      10                           10                      60            3     33.3   29.3
  Rifampicin                           19                      10.5                         10                      10            6     66.7   20
  Levofloxacin                         20                      30                           10                      60            6     50     41.7
  Clindamycin                          1                       100                          ---                     ---           2     0      33.3
  Streptomycin                         13                      46.2                         3                       100           ---   ---    56.3
  Erythromycin                         19                      31.6                         10                      60            6     66.7   45.7
  Linezolid                            15                      0                            10                      0             4     ---    0
  Vancomycin                           20                      10                           10                      20            5     40     17.1
  Achromycin                           7                       42.9                         6                       33.3          3     66.7   43.8
  Nitrofurantoin                       13                      0                            5                       0             3     ---    0
  sulbactam sodium                     13                      15.4                         4                       25            2     50     21.1
  Ceftazidime                          14                      14.3                         4                       100           3     66.7   38.1
  Moxifloxacin                         18                      22.2                         10                      30            1     0      24.1
  Amoxicillin/clavulanate potassium.   19                      63.2                         8                       100           1     100    75
  Cefotaxime                           14                      28.6                         4                       75            3     33.3   38.1
  Gentamicin                           20                      10                           10                      60            3     33.3   27.3

Numb. = number of plants; R = drug resistance rate; "-" = not applicable.

###### 

Drug Resistance of Single Bacterial Surgical Site Infections in Orthopedics

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Baumann/Acinetobacter\   Escherichia coli   Pseudomonas aeruginosa   Enterobacter cloacae     Staphylococcus aureus                                                                                                                                 
  haemolyticus                                                                                                                                                                                                                                        
  ------------------------ ------------------ ------------------------ ------------------------ ----------------------- ------- ------------------------ ----- ------- ---------------------------- ----- ------- ----------------------------- ----- -------
  Cefotetan                87                 81                       ceftetan                 90                      5.53    ceftetan                 73    97.24   ceftetan                     80    83.77   penicillin                    95    97.89

  Cefazolin                84                 78                       Amikacin                 156                     8.32    Amikacin                 99    10.09   amikacin                     140   52.15   Amoxicillin/clavulanic acid   97    52.59

  Ceftriaxone              103                77.01                    Cefazolin                138                     81.14   Cefazolin                74    100     Amoxicillin/claulanic acid   111   71.18   Ceftriaxone                   87    57.47

  Cefepime                 105                68.98                    Ceftriaxone              136                     77.18   Ceftriaxone              96    94.78   Cefazolin                    125   98.39   Levofloxacin                  125   20.81

  Levofloxacin             106                57.99                    Cefepime                 139                     41.72   Cefepime                 101   16.82   Ceftriaxone                  120   35.01   Tetracycline                  119   30.24

  Tobramycin               100                55                       Levofloxacin             158                     50.61   Levofloxacin             100   13.99   Cefepime                     125   16.71   Moxifloxacin                  111   8.1

  Cefoperazone/sulbactin   91                 23.01                    Tetracycline             68                      67.66   Tobramycin               85    12.93   Levofloxacin                 138   6.53    Ciprofloxacin                 126   24.59

  Ceftazidine              103                57                       Tobramycin               143                     27.28   Cefoperazone/sulbactam   69    13.04   Piperacillin                 108   26.86   Gentamicin                    123   29.02

  Ciprofloxacin            102                67                       Cefoperazone/sulbactam   117                     5.96    Ceftazidine              97    22.69   Tetracycline                 96    14.58   Compound neoprene             127   14.16

  Gentamicin               106                62.04                    Ceftazidine              154                     47.41   Ciprofloxacin            101   17.83   Ciprofloxacin                125   18.41   Ticarcillin                   29    0

  Meropenem                95                 59.99                    Ciprofloxacin            158                     49.87   Gentamicin               101   14.85   Cefoperazone/sulbactam       108   7.4     Ampicillin/sulbactam          84    59.51

  Compound xinnomin        105                63                       Gentamicin               148                     50.66   Meropenem                71    18.32   Ceftadime                    137   24.09   Ampicillin                    97    100

  Imipenem                 92                 58.99                    Meropenem                137                     8.02    Compound neoprene        87    86.2    Ciprofloxacin                135   11.1    Clocomycin                    126   68.25

  Ampicillin/sulbactam     96                 62.1                     Trimoxazole              154                     59.73   Impenem                  101   15.84   Gentamicin                   140   17.87   Erythromycin                  124   70.16

  Ampicillin               86                 80                       Ertapenem                133                     9.01    Ampicillin/sulbactam     65    96.93   Meropenem                    126   8.73    Benzoxacillin                 124   52.41

  Ammonia quna             80                 67                       Imipenem                 159                     5.66    Ampicillin               79    97.47   Trimethoprim                 137   21.15   Linezolid                     122   0

  Paracillin/tazobar       89                 55                       Ampicillin/sulbactam     87                      65.52   Paracillin/tazobar       97    17.52   Ertapenem                    118   12.71   Rifampicin                    125   9.57

  Nitrofurantoin           84                 73.01                    Ampicillin               157                     93      Nitrofurantoin           71    97.17   Imipenem                     140   12.87   Nitrofurantoin                34    0
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Num = number of bacteria tested for drug sensitivity; R = drug resistance rate.

Discussion {#s008}
==========

Our results revealed the presence of two to seven kinds of bacterial infections in each wound, of which two kinds of bacteria, accounting for 65.1%, caused the most infections. The number of infections decreased as the number of strains increased. The four combinations of pathogenic bacteria present in our study included all gram-negative bacteria, mixed gram-negative and gram-positive bacteria, all gram-positive bacteria, and mixed gram-positive bacteria and fungi. In particular, only combinations of two gram-positive bacteria were found in mixed infections caused solely by the combination of pure gram-positive bacteria, and no mixed infections caused by more than two gram-positive bacteria were found.

In the ecosystem of orthopedic surgical sites, when the absolute amount of living space and nutrients is insufficient, two or more microbial groups compete for the same resources. Antagonistic micro-organisms can also capture water and nutrients, occupy space, consume oxygen, and other resources by rapid growth and reproduction to eliminate other groups of pathogens in the same habitat \[[@B5],[@B6]\]. These resources include nutrients, oxygen, and space. Therefore, competition types are divided into nutritional competition and spatial competition. This competition results in fewer infections as the number of strains increase.

No relevant literature reports that the coexistence of more than two gram-positive bacteria will lead to strong inter-specific competitions, which limits their strains. This may be related to the overall infection of bacteria---mainly gram-negative bacteria. From 2012 to 2017, 86 patients experienced mixed incisional infections after orthopedic operation. In all, the recorded 218 strains of bacteria, including 152 strains of gram-negative bacteria (69.72%), 65 strains of gram-positive bacteria (29.81%), and one strain of fungus (0.47%), confirm the report that the main infection after orthopedic surgical procedures is gram-negative bacterial infection.

*E. cloacae*, *S. aureus, P. aeruginosa*, *E. coli,* and *Baumann/A. haemolyticus* were the most common mixed infections in our hospital. This is generally consistent with the reported pathogenic bacteria in most orthopedic surgical site infections \[[@B7]\]. The foot, leg, forearm, and knee were the most common sites of infection. Gram-positive bacteria were susceptible to linezolid and furantoin, ampicillin, and amoxicillin/clavulanate potassium. Gram-negative bacteria are highly sensitive to cefoperazone/sulbactam sodium and meropenem and fairly sensitive to ampicillin, aztreonam, and amoxicillin/clavulanate potassium. This is consistent with the bacterial resistance of 447 cases of single bacterial surgical site infections during the same period.

The distribution, quantity, and drug resistance of bacteria in mixed surgical site infection after orthopedic operation are not significantly different from those caused by a single pathogen because of the interaction between pathogens. Mixed infections of orthopedic surgical sites form a small ecosystem. Its composition and stable population dynamics ultimately come from the interaction between organisms \[[@B10]\]. Various kinds and high concentration of micro-organisms exist in the biologic environment, but the existing and relatively small available space enables coevolution with unique physical and chemical interactions among species.

Some microorganisms have evolved mutually or even synergistically to promote cohabitation and efficient utilization of metabolic byproducts in the same ecosystem, while others have developed competitive antagonistic methods in the process of cocloning. One bacterium can affect the niche of the reproduction of another bacterium in the wound, making it easy to be colonized by pathogenic bacteria or caused by two or more non-pathogenic micro-organisms. For example, cystic fibrosis in the lung is often caused by *P. aeruginosa*, *S. aureus*, *Haemophilus influenzae, Burkholderia cepacia,* and other bacteria. These bacteria developed increased resistance through metabolic feeding or quorum sensing (QS)-related signaling mechanisms, bacterial tolerance, and biofilm development \[[@B11]\] in adults. *S. epidermidis* and *S. aureus* compete for nasal mucosal colonization and ESP-serine protease-producing *S. epidermidis* strains to eradicate *S. aureus* nasal colonization.

Mixed surgical site infection after orthopedic operation is not uncommon because the site is close to the body surface. Because *S. aureus* has always been a common bacterium in orthopedic surgical site infections, Regev-Yochay et al. \[[@B15]\] and Bogaert et al. \[[@B16]\] investigated another interaction: *S. aureus* carriers and the effect of pneumococcal conjugate vaccination on the increase of the carrying capacity of *S. aureus* and *S. aureus*-related diseases, and microbial interference with the protection ability of *S. pneumoniae* carriers, respectively.

Armbruster et al. \[[@B17]\] found that secretory staphylococcal protein ASpA inhibited biofilm formation of specific clinical isolates of *P. aeruginosa* and phagocytosis of neutrophils to all clinical isolates tested. Through reverse transcription polymerase chain reaction and other methods, Deng et al. \[[@B18]\] found that the cis-2-dodecanoic acid produced by *B. cepacia* mediated the communication with *P. aeruginosa* by interfering with the QS system and type III secretory system, which resulted in biofilm formation and virulence of *P. aeruginosa*. For down-regulation of force factor synthesis, Alex et al. \[[@B19]\] found that compared with single infection, the adhesion of *E. coli* and *Citrobacter freundii* to HeLa cells increased significantly. Moreover, *E. coli* carrying F-pili gene (traA) could form bacterial aggregates only in the presence of *C. freundii*.

Meanwhile, scanning electron microscopy analysis showed that both bacterial aggregates and enhanced biofilms formed by coinfection were mediated by flexible pili. In addition, the use of specific inhibitors of F-pili significantly reduced the formation of mixed infectious bacterial membranes. The results show, however, that the distribution, quantity, and drug resistance of mixed infections and post-operative infections caused by a single pathogen do not differ significantly because of the interaction between pathogens.

Our study shows that mixed surgical site infection significantly prolongs hospital stay. This may be related to the poor basic condition of patients with mixed infections, low immunity, and the difficulty of single antibiotic agents to cover the sensitive range of their bacteria. Other studies speculate that when mixed infections are found, doctors may extend the hospital stay to ensure infection control even after reaching discharge indications for fear that the infection will not be controlled completely.

Mixed infection after orthopedic operation is caused by many kinds of pathogenic bacteria and various combinations of pathogenic bacteria, which are difficult to control and prolonge hospitalization duration. It is difficult for conventional single or compound antibiotic agents to target surgical sites simultaneously caused by gram-negative bacteria and gram-positive bacteria. Moreover, published literature shows that more than two antibiotic agents are independent risk factors for infection after orthopedic surgical procedures, and various antibiotic agents aggravate the burden of patients, which necessitates strict matching of antibiotic agents sensitive to pathogenic bacteria according to drug sensitivity, so as to avoid unreasonable matching of antibiotic agents \[[@B20]\].

Age \>60 years, body mass index \>26.5 kg/m^2^, hypertension, diabetes mellitus \[[@B21]\], coronary heart disease, chronic obstructive pulmonary disease, malnutrition, hypoproteinemia, and so on, are all risk factors of infection after orthopedic operation \[[@B19]\]. (Thus, it is necessary o improve immunity by active symptomatic treatment before operation.

Factors affecting the contact probability and time of pathogenic bacteria can be prevented by adjusting the treatment plan and making full use of protective factors, such as controlling the operation duration and laminar flow in operating rooms. In addition, the presence of infection before operation is an important reason for early infection after operation; thus, it is necessary to screen for occult infection to avoid infection.

Conclusion {#s009}
==========

The importance of multi-microbial diseases and interaction between human health and disease-related microbial communities have been recognized by the medical community. The multi-microbial causes of diseases and the effects of treatment, prevention, and prognosis have also been considered. Actively enhancing the immune capacity of patients and actively controlling factors affecting the probability of contact and time of pathogenic bacteria are strategies to prevent infections.

Our study indicated that the distribution, quantity, and drug resistance of bacteria in mixed surgical site infection after orthopedic surgical procedures are not significantly different from those caused by a single pathogen because of the interaction between pathogens. Various kinds of pathogenic bacteria are present in mixed infections after orthopedic operations. These bacteria are difficult to control, resulting in significantly prolonged hospitalization.

Use of conventional single or compound antibiotic agents may be ineffective in managing surgical sites, when both gram-negative and gram-positive bacterial infections are present. This necessitates that antibiotic agents sensitive to pathogenic bacteria should be matched strictly according to drug sensitivity to avoid ineffective antibiotic matching and minimize unnecessary administration of antibiotic agents to patients, which would create a greater burden to the body.

The datasets used or analyzed during the current study are available from the corresponding author on request.
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